Location History:
- Franklin, TN (US) (2010)
- Nashville, TN (US) (2013)
Company Filing History:
Years Active: 2010-2013
Title: Ray Mernaugh: Innovator in Cancer Therapeutics
Introduction
Ray Mernaugh is a distinguished inventor based in Nashville, TN (US), known for his contributions to the field of cancer research. With a focus on immunological compositions and cancer biomarkers, he has made significant strides in developing therapeutic solutions for cancer treatment. Mernaugh holds 2 patents that reflect his innovative approach to tackling complex medical challenges.
Latest Patents
Mernaugh's latest patents include "Immunological compositions as cancer biomarkers and/or therapeutics." This invention concerns antibodies that react immunologically with anti-tumor antigen antibodies, providing methods related to cancer diagnostics and therapeutics, particularly for breast cancer. Another notable patent is "Targeting of Notch3 receptor function for cancer therapy," which involves the use of peptides from Notch3 and antibodies that recognize these peptides as anti-cancer agents. This patent also outlines methods for combination therapy using standard anti-cancer protocols alongside Notch3 peptides and antibodies.
Career Highlights
Ray Mernaugh is affiliated with Vanderbilt University, where he continues to advance his research in cancer therapeutics. His work has garnered attention for its potential to improve cancer treatment outcomes and enhance diagnostic capabilities.
Collaborations
Mernaugh collaborates with esteemed colleagues such as Thao P Dang and David P Carbone, contributing to a dynamic research environment focused on innovative cancer therapies.
Conclusion
Ray Mernaugh's contributions to cancer research through his patents and collaborations highlight his commitment to improving therapeutic options for patients. His work exemplifies the impact of innovation in the medical field.